Vital Signs: Can a Catalent-powered manufacturing boost solve the problems at Novo Nordisk? - FirstWord Pharma

Vital Signs: Can a Catalent-powered manufacturing boost solve the problems at Novo Nordisk?  FirstWord Pharma